NIH clinical trial testing hyperimmune intravenous immunoglobulin plus remdesivir to treat COVID-19 Begins
The study is taking place in hospitalized adults in the United States, Mexico and 16 other countries.
Source: National Institutes of Health (NIH) News Releases - Category: American Health Source Type: news
More News: American Health | Clinical Trials | COVID-19 | Mexico Health | National Institutes of Health (NIH) | Study | USA Health